Nobska Point Capital logo

Nobska Point Capital

North America, Massachusetts, United States, Boston

Description

A Micro-VC firm based in Boston. Invests in very early stage start-ups in the F/F, Angel, and Seed rounds

Investor Profile

Nobska Point Capital has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Pre Seed, Convertible Note rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on E-Commerce, FinTech, Mobile Payments.

Stage Focus

  • Series Unknown (33%)
  • Pre Seed (33%)
  • Convertible Note (33%)

Country Focus

  • United States (100%)

Industry Focus

  • E-commerce
  • Fintech
  • Mobile Payments
  • Software
  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Medical Device
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Nobska Point Capital frequently co-invest with?

LaunchPad Venture
North America, Massachusetts, United States, Newton
Co-Investments: 1
Techstars
North America, Colorado, United States, Boulder
Co-Investments: 1
Everywhere Ventures (The Fund)
North America, New York, United States, New York
Co-Investments: 1
Chingona Ventures
North America, Illinois, United States, Chicago
Co-Investments: 1
Alopexx
North America, Massachusetts, United States, Concord
Co-Investments: 1

What are some of recent deals done by Nobska Point Capital?

Paerpay

Boston, Massachusetts, United States

Paerpay helps merchants accept contactless payments without the hassle of changing point-of-sales systems.

E-CommerceFinTechMobile PaymentsSoftware
Pre SeedMar 22, 2021
Amount Raised: $753,000
Paerpay

Boston, Massachusetts, United States

Paerpay helps merchants accept contactless payments without the hassle of changing point-of-sales systems.

E-CommerceFinTechMobile PaymentsSoftware
Convertible NoteFeb 1, 2020
Amount Raised: $335,000
Cognoptix

Marlborough, Massachusetts, United States

Cognoptix develops non-invasive eye tests for the early diagnosis of alzheimer disease.

BiotechnologyHealth CareHealth DiagnosticsMedical DeviceTherapeutics
Series UnknownDec 15, 2019
Amount Raised: $1,300,000